RESULTS OF LAPAROSCOPIC THORACIC-ABDOMINAL SURGERY TO REPLACE THE ESOPHAGUS WITH THE STOMACH TO TREAT CANCER OF THE LOWER 2/3 ESOPHAGUS AT MILITARY HOSPITAL 175

Thao Trinh Van; Manh Nguyen Van; Cuong Truong Duc; Thong Nguyen Phu; Giao Doan Ngoc

doi:10.59354/ydth175.2024.263

Keywords:

Laparoscopic esophagectomy, esophageal cancer

Abstract

Objective: To evaluate the effectiveness and safety of laparoscopic thoracic-abdominal esophagectomy and create a replacement gastric tube in the treatment of lower 2/3 esophageal cancer at Military Hospital 175

Subjects and methods: A prospective study, cross-sectional description of 34 cases of lower 2/3 esophageal cancer undergoing laparoscopic thoracoabdominal esophagectomy and creating a replacement gastric tube at Military Hospital175 from July 2015 to March 2022. Initially, technical support was provided by Cho Ray Hospital.

Results: All patients were male; the mean age was 55.2 ± 10.2 (28-79) years, 76.5% with a history of smoking and drinking alcohol. Cancer was located in the lower third of the esophagus in 58.8% of cases, middle third accounted for 41.2%. All cases (100%) were squamous cell carcinoma. According to AJCC 8th edition, the disease stages were stages II, III, and IV at rates of 50%, 47.1%, and 2.9% respectively. The ratio of successful surgery was 100%. The average duration of surgery was 387.4 ± 69.6 minutes, of which the thoracic phase was 174.9 ± 61.6 minutes, the abdominal phase was 150.3 ± 34.9 minutes, and the cervical phase was 62.2 ± 22.3 minutes. Complications in operation accounted for 14.7% of cases and were all managed successfully. The postoperative complication rate was 44.1%, including pneumonia was 14.7%, hoarseness was 35.3%, collapsed lung 5.9%, anastomotic leak was 5.9%, and and no mortality (0%). Quality of life after surgery: good 58.6%, average 31.0%, poor 10.3%. The average survival time after surgery was 25.5 ± 2.5 months, one year 77.4%, two years 56.7%, three years 24.3%.

Conclusions: Laparoscopic thoracoabdominal esophagectomy and the creation of a replacement gastric tube were successfully performed at Military Hospital 175 with a favorable complication rate, survival time, and significantly improved quality of life.

References

Trieu Trieu Duong and Tran Huu Vinh (2014). “ Evaluating the results of treatment of middle-lower 1/3 esophageal cancer by endoscopic surgery”.” Practical Medicine, 902.

Ferguson M.K. and Durkin A.E. (2002). Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. The Journal of Thoracic and Cardiovascular Surgery, 123(4), 661–669.

Haefner M.F., Lang K., Verma V., et al. (2018). Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure. Strahlenther Onkol, 194(2), 116–124.

Nguyen Xuan Hoa (2015). “ Evaluate the results of endoscopic thoracoabdominal esophagectomy with 2-region wide lymph node dissection.” Scientific conference on Endoscopic and Thoracic Surgery and General Surgery of Vietnam, 2.

Fan Y., Yuan J.-M., Wang R., et al. (2008). Alcohol, Tobacco and Diet in Relation to Esophageal Cancer: The Shanghai Cohort Study. Nutr Cancer, 60(3), 354– 363.

Alghamedi A., Buduhan G., Tan L., et al. (2018). Quality of life assessment in esophagectomy patients. Ann Transl Med, 6(4), 84.

Ajani J.A., D’Amico T.A., Bentrem D.J., et al. (2023). Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(4), 393–422.

Luketich J.D., Pennathur A., Awais O., et al. (2012). Outcomes After Minimally Invasive Esophagectomy. Ann Surg, 256(1), 95–103.

Akiyama H., Miyazono H., Tsurumaru M., et al. (1978), “Use of the stomach as an esophageal substitute”, Ann Surg, 188(5), 606-610.

Miyamoto S, Nakao J, Higashino T, Yoshimoto S, Hayashi R, Sakuraba M. Clavien-Dindo classification for grading complications after total pharyngolaryngectomy and free jejunum transfer. PLoS One. 2019 Sep 12;14(9).